Autoimmune diseases as the loss of active "self-control"

被引:35
作者
Bach, JF [1 ]
机构
[1] Hop Necker Enfants Malad, INSERM, U580, F-75015 Paris, France
来源
MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION | 2003年 / 998卷
关键词
immunoregulation; CD25+T cells; NKT cells; autoimmune diseases;
D O I
10.1196/annals.1254.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Converging experimental evidence indicates that the clinical expression of autoimmunity is under the control of T cell-mediated immunoregulatory circuits. Several types of suppressor T cells have been described. Some of them are closely dependent upon cytokines such as TH2 cells and Tr1 cells. Others appear to rely more on cell-cell contact (such as CD25+ CD62L+ T cells), although some cytokines, notably TGF-beta, may be involved in their growth or their mode of action. It is tempting to separate suppressor cells that appear spontaneously, such as CD25+ T cells and NKT cells (innate immunoregulation), from those that are only observed after antigen administration, such as TH2 cells and Tr1 cells (adaptive immunoregulation). The role of these diverse cell types in the control of the onset or the progression of autoimmune diseases is likely, but still a matter of debate. A central question is to determine whether immune dysregulation precedes the burst of pathogenic autoimmunity.
引用
收藏
页码:161 / 177
页数:17
相关论文
共 120 条
[1]   Homeostasis of peripheral CD4+ T cells:: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers [J].
Almeida, ARM ;
Legrand, N ;
Papiernik, M ;
Freitas, AA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (09) :4850-4860
[2]   Progression of autoimmune diabetes driven by avidity maturation of a T-cell population [J].
Amrani, A ;
Verdaguer, J ;
Serra, P ;
Tafuro, S ;
Tan, RS ;
Santamaria, P .
NATURE, 2000, 406 (6797) :739-742
[3]   Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease [J].
Arkwright, PD ;
David, TJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (03) :531-534
[4]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[5]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[6]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[7]   Protective role of infections and vaccinations on autoimmune diseases [J].
Bach, JF .
JOURNAL OF AUTOIMMUNITY, 2001, 16 (03) :347-353
[8]   Tolerance to islet autoantigens in type 1 diabetes [J].
Bach, JF ;
Chatenoud, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :131-161
[9]   IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse [J].
Balasa, B ;
Van Gunst, K ;
Jung, N ;
Katz, JD ;
Sarvetnick, N .
CELLULAR IMMUNOLOGY, 2000, 202 (02) :97-102
[10]  
Balasa B, 1998, J IMMUNOL, V161, P2856